Professor for Neurology and Psychiatry, Dr. Arndt Rolfs is the CEO and Founder of Centogene AG. He received his approbation for human medicine in 1985 from the University of Mainz, Germany and the University of Vienna, Austria. Arndt is a principle investigator of several international multicenter studies in the area of rare diseases and actively engaged in biomarker research for several metabolic diseases, including the Sifap project (www.sifap.eu), the world’s largest study in young stroke patients related to Fabry disease, several biomarker studies (e.g. BioHAE, BioGaucher, BioHunter, BioMorquio) and epidemiological studies in neurogenetic aetiologies. Dr. Rolfs has an extensive track record in medical and scientific publications with over 300 papers published in peer-reviewed scientific journals.